KV3.2 Antibodies

Santa Cruz Biotechnology features a diverse variety of KV3.2 monoclonal antibodies for advanced research in neuroscience and cellular biology. KV3.2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). KV3.2, also known as KCNB2, is a voltage-gated potassium channel that plays a critical role in the repolarization of action potentials in neurons, contributing to the regulation of neuronal excitability and firing frequency. Proper functioning of KV3.2 is essential for maintaining the balance of electrical activity in the nervous system. Disruption of KV3.2 function has been linked to various neurological disorders. Research focused on KV3.2 continues to reveal new insights about cellular processes and potential therapeutic approaches. Understanding KV3.2's role in neuronal signaling pathways helps identify novel treatment strategies for neurological conditions. Investigating KV3.2 expression patterns provides valuable information about brain circuit function and development. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance our understanding of neuroscience and contribute to breakthrough discoveries in neurological research.